Skip to main content
LIFE

DYNOCARDIA

Enlightened blood-pressure management

IF WE MONITOR BLOOD PRESSURE ACCURATELY AND CONTINUOUSLY, CAN WE SAVE BILLIONS OF LIVES GLOBALLY?

There is an unmet need for accurate and continuous non-invasive blood pressure (cNIBP) monitoring. Problems stemming from inaccurate, intermittent (single-time-point) BP measurement and sub-therapeutic management of BP are particularly pronounced in hospitals, where currently, the only option for continuous measurement is the invasive intra-arterial catheter, which can lead to clinically significant complications. The other option, cuffed devices, provide only intermittent and often inaccurate BP readings.

The first standalone cuffless, wearable technology to measure BP accurately and continuously

 

BREAKTHROUGH IDEA

Dynocardia’s proprietary ViTrack™ methodology is the technology behind ViTrack, a wrist- wearable device with the processing power to enable continuous beat-to-beat BP monitoring. ViTrack technology is poised to surmount century-old obstacles to obtaining accurate and continuous measurement of BP by enabling ambulatory and nocturnal measurement. Additionally, ViTrack technology holds great promise for improving outcomes in 1.5 billion people living with hypertension around the world, who are at heightened risk for stroke and heart attacks.

ViTrack™: New method and technology

 

POSITIVE IMPACT ON THE SOCIETY

GOAL 3: GOOD HEALTH AND WELL-BEING

GOAL 3 - Good Health and Well Being

 

BENEFITS TO USE THE 3DEXPERIENCE PLATFORM ON THE CLOUD

“We are so grateful to 3DS for their interest in our work and investment in our efforts” says Dynocardia founder Mohan Thanikachalam, MD. We believe that their state-of-the-art prototyping facilities located here in Boston, along with 3DS’s product-development-software portfolio, automated platform for clinical trial recruitment, and strength of their engineering, IT, and design teams worldwide will allow us to commercialize ViTrack™ much faster than we’d have been able to otherwise.

 

COLLABORATIVE & COLLECTIVE INTELLIGENCE 

Over the coming decade, ViTrack has the potential to monitor BP in billions of people and aggregate this real-world data in the cloud for unprecedented research opportunities for the prevention of cardiovascular disease. In addition to BP, ViTrack can provide heart rate, respiratory and other valuable cardio-hemodynamic data.

Meet the team

The Dynocardia team is deeply committed to improving the lives of billions of people via accurate and continuous BP monitoring.

  • Mohan  Thanikachalam
    Mohan Thanikachalam
    MD, Co-founder, CEO
  • Abhijit Biswas
    Abhijit Biswas
    PhD, Co-founder, CTO
  • Edward Adelson
    Edward Adelson
    PhD, Founder, Core Tech Lead
  • Mark  Kotfila
    Mark Kotfila
    MSECE Product Development Lead
  • Chelsey  Ryan
    Chelsey Ryan
    BS, Commercialization Lead
  • Carly  Chase
    Carly Chase
    BA Head, Finance and Strategic Partnership Initiatives
  • Gokul Prasath  Rajamanickam
    Gokul Prasath Rajamanickam
    Product Manager

Similar projects

Submit your project

Do you think your project is the next big thing?
Join the team !

Submit your project